share_log

Atossa Therapeutics | 10-K: FY2024 Annual Report

SEC ·  Mar 25 12:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 404

Recommended